Author:
Appleby Timothy D.,Quinn Killian J.
Reference40 articles.
1. The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities;Anderson;Clinical Infectious Diseases,2008
2. British HIV Association, 2016. BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update). Accessed online 14/12/2016 [Internet]. Vol. 2015. [cited 2020 May 27]. Available from: http://www.bhiva.org/HIV-1-treatment-guidelines.aspx.
3. Adverse effects of antiretroviral therapy;Carr;Lancet,2000
4. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine;Cihlar;Antiviral Research,2010
5. Doravirine: A review;Colombier;Current Opinion in HIV and AIDS,2018